Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Found vs NowPatient

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Found logo

Found

8.3
★★★★4.2/5

Best for: mainstream telehealth GLP-1 access

Visit Found
VS
NowPatient logo

NowPatient

6.9
★★★3.5/5

Best for: Brand-name GLP-1 access without a compounded route

Visit NowPatient

Found and NowPatient are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Found starts lower at $149/mo versus $1069/mo, and Found edges ahead overall (8.3 vs 6.9 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

NowPatient

Mounjaro (brand, cash-pay)Brand-name
$1069/mo
tirzepatide
Wegovy injection (brand, cash-pay)Brand-name
$1349/mo
semaglutide
Wegovy oral tablet (brand, cash-pay)Brand-name
$1349/mo
semaglutide
Saxenda (brand, cash-pay)Brand-name
$1349/mo
liraglutide

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 390+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Found

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

NowPatient

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Found

8.3/10

Overall

NowPatient

6.9/10

Value25%

8.5A
vs
B
4.0

Effectiveness25%

9.0A
vs
B
8.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

7.3A
vs
B
8.0

Accessibility10%

8.5A
vs
B
7.5

Support10%

7.5A
vs
B
7.9

Features & Coverage

FeatureFoundNowPatient
Starting Price$149/mo$1069/mo
Features3 features2 features
States Available50Not disclosed
Compounded✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Found

Personalized weight care platform with a self-pay membership model plus medication costs.

Read our full Found review →

About NowPatient

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Consultations are free and patients pay only the cost of the prescribed medication, which means out-of-pocket tracks brand list prices (~$1,000-$1,350/mo without insurance). HQ Austin, TX.

Read our full NowPatient review →

Pros & Cons

Found

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

NowPatient

What we like

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Watch-outs

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Our Verdict

Winner: Found

Found edges out NowPatient with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.

Choose Found if…

You want mainstream telehealth GLP-1 access and a starting price around $149/mo.

Choose NowPatient if…

You want Brand-name GLP-1 access without a compounded route and a starting price around $1069/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Sprout Health

LegitScript-verified compounded GLP-1 via named pharmacies

7.5

PeterMD

Men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy

7.8

Care Bare Rx

LGBTQ+-inclusive compounded GLP-1 telehealth

Found vs NowPatient: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Found and NowPatient head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.